CalciMedica, Inc. (CALC) Insider Trading
Directors, officers and holders of more than 10% of CALC report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 116 transactions on file: 15 with code P, 1 with code S and 34 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Guerard Frederic | Director | A Award | 20,000 | Not measured | Not measured |
| Oct 1, 2026 | WILSON ROBERT N | Director | A Award | 20,000 | Not measured | Not measured |
| Oct 1, 2026 | Glicklich Alan | Director | A Award | 20,000 | Not measured | Not measured |
| Oct 1, 2026 | Zaytsev Evgeny | Director | A Award | 20,000 | Not measured | Not measured |
| Oct 1, 2026 | Shaw Allan | Director | A Award | 20,000 | Not measured | Not measured |
| Sep 24, 2026 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award | 360,000 | Not measured | Not measured |
| Sep 24, 2026 | Bardin Stephen | Chief Financial Officer | A Award | 190,000 | Not measured | Not measured |
| Sep 24, 2026 | Hebbar Sudarshan | Chief Medical Officer | A Award | 180,000 | Not measured | Not measured |
| Sep 24, 2026 | Stauderman Kenneth A. | Chief Scientific Officer | A Award | 180,000 | Not measured | Not measured |
| Aug 19, 2026 | Hebbar Sudarshan | Chief Medical Officer | A Award | 124,486 | Not measured | Not measured |
| Aug 19, 2026 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award | 186,729 | Not measured | Not measured |
| Aug 19, 2026 | Hebbar Sudarshan | Chief Medical Officer | A Award | 124,486 | Not measured | Not measured |
| Aug 19, 2026 | ALAFI CAPITAL CO LLC | 10% Owner | A Award | 3,529,192 | Not measured | Not measured |
| Aug 19, 2026 | ALAFI CAPITAL CO LLC | 10% Owner | A Award | 3,529,192 | Not measured | Not measured |
| Aug 19, 2026 | WILSON ROBERT N | Director | A Award | 1,182,621 | Not measured | Not measured |
| Aug 19, 2026 | Zaytsev Evgeny | Director | A Award | 1,450,267 | Not measured | Not measured |
| Aug 19, 2026 | Guerard Frederic | Director | A Award | 10,000 | Not measured | Not measured |
| Aug 19, 2026 | Zaytsev Evgeny | Director | A Award | 10,000 | Not measured | Not measured |
| Aug 19, 2026 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award | 186,729 | Not measured | Not measured |
| Aug 19, 2026 | Roberts Eric W | CHIEF BUSINESS OFFICER | A Award | 186,729 | Not measured | Not measured |
| Aug 19, 2026 | Shaw Allan | Director | A Award | 10,000 | Not measured | Not measured |
| Aug 19, 2026 | Zaytsev Evgeny | Director | A Award | 1,450,267 | Not measured | Not measured |
| Aug 19, 2026 | Glicklich Alan | Director | A Award | 10,000 | Not measured | Not measured |
| Aug 19, 2026 | Roberts Eric W | CHIEF BUSINESS OFFICER | A Award | 186,729 | Not measured | Not measured |
| Aug 19, 2026 | WILSON ROBERT N | Director | A Award | 10,000 | Not measured | Not measured |
| Aug 19, 2026 | WILSON ROBERT N | Director | A Award | 1,182,621 | Not measured | Not measured |
| Jul 2, 2026 | Zaytsev Evgeny | Director | A Award | 20,000 | Not measured | Not measured |
| Jun 25, 2026 | Hebbar Sudarshan | Chief Medical Officer | A Award | 24,897 | $4.02 | $100,000 |
| Jun 25, 2026 | Roberts Eric W | CHIEF BUSINESS OFFICER | A Award | 37,346 | $4.02 | $149,999 |
| Jun 25, 2026 | Middleton Fred A | Director | P Purchase | 49,794 | $4.02 | $199,999 |
| Jun 25, 2026 | Leheny A. Rachel | CHIEF EXECUTIVE OFFICER | A Award | 37,346 | $4.02 | $149,999 |
| Jun 25, 2026 | WILSON ROBERT N | Director | A Award | 236,524 | $4.02 | $949,999 |
| Oct 13, 2025 | Glicklich Alan | Director | A Award | 937 | Not measured | Not measured |
| Sep 18, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 500 | $15.35 | $7,675 |
| Sep 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 680 | $13.39 | $9,105 |
| Sep 12, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 1,000 | $15.60 | $15,600 |
| Sep 9, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 469 | $15.74 | $7,378 |
| Aug 29, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 160 | $13.70 | $2,192 |
| Aug 28, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 1,840 | $14.31 | $26,340 |
| Aug 21, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 702 | $13.96 | $9,797 |
| Aug 20, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | M Exercise | 15,000 | $1.53 | $22,950 |
| Aug 20, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | M Exercise | 3,000 | $7.65 | $22,950 |
| Aug 20, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 400 | $13.60 | $5,440 |
| Aug 19, 2025 | Hebbar Sudarshan | Chief Medical Officer | P Purchase | 1,913 | $14.10 | $26,962 |
| Aug 19, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 200 | $13.95 | $2,790 |
| Aug 15, 2025 | Roberts Eric W | CHIEF BUSINESS OFFICER | P Purchase | 1,015 | $14.49 | $14,709 |
| Aug 15, 2025 | Hebbar Sudarshan | Chief Medical Officer | P Purchase | 878 | $13.96 | $12,267 |
| Aug 14, 2025 | Hebbar Sudarshan | Chief Medical Officer | P Purchase | 317 | $12.92 | $4,095 |
| Jul 28, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | P Purchase | 200 | $19.80 | $3,960 |
| Jul 25, 2025 | Stauderman Kenneth A. | Chief Scientific Officer | S Sale | 200 | $18.25 | $3,650 |
The full Form 4 history is on the CALC company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.